as 12-18-2024 1:31pm EST
Founded: | 2018 | Country: | United States |
Employees: | N/A | City: | WALTHAM |
Market Cap: | N/A | IPO Year: | 2021 |
Target Price: | $11.75 | AVG Volume (30 days): | 185.6K |
Analyst Decision: | Hold | Number of Analysts: | 7 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -2.98 | EPS Growth: | N/A |
52 Week Low/High: | $1.25 - $32.42 | Next Earning Date: | 11-12-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
AVTE Breaking Stock News: Dive into AVTE Ticker-Specific Updates for Smart Investing
BioPharma Dive
2 months ago
GlobeNewswire
2 months ago
MT Newswires
5 months ago
BioPharma Dive
5 months ago
GlobeNewswire
5 months ago
Clinical Trials Arena
6 months ago
Zacks
6 months ago
MT Newswires
6 months ago
The information presented on this page, "AVTE Aerovate Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.